Pre-market news summary for US stocks

① U.S. stock index futures all fell: Dow futures dropped 0.37%, S&P 500 futures fell 0.36%, and Nasdaq futures decreased by 0.54%.

② European stock market indices all declined: Germany's DAX30 fell 0.17%, France's CAC40 dropped 0.90%, the Euro Stoxx 50 decreased by 0.62%, and the UK's FTSE 100 fell 0.66%.

③ The Federal Reserve lowered the benchmark interest rate by 25 basis points to 3.75%-4.00%, marking the second consecutive meeting of rate cuts, in line with market expectations.

④ BlackRock expects the Federal Reserve to cut rates again in December, believing that a weak labor market is conducive to a decline in inflation, while maintaining a risk appetite stance; it also pointed out that a loose financial environment and high stock market levels will not hinder the rate-cutting process.

⑤ The World Gold Council stated that global gold demand in Q3 2025 is expected to increase by 3% year-on-year to 1,313 tons, setting a new historical quarterly high, with investment demand soaring 44% year-on-year to $146 billion.

⑥ Weight loss drug company Metsera's pre-market gains expanded by nearly 20%, as Novo Nordisk plans to "swoop in" with a maximum of $9 billion to acquire Pfizer's agreement, which Pfizer criticized as "reckless."

⑦ Google rose over 8% in pre-market trading, with the company's Q3 revenues from cloud computing, advertising, and video exceeding analyst expectations, and significantly raised its full-year capital expenditure. Morgan Stanley raised its target price from $300 to $340.

⑧ Meta fell nearly 10% in pre-market trading, with the company's Q3 net profit at $2.7 billion, far below analyst expectations, and the company plans to raise at least $25 billion through bond issuance.

⑨ Microsoft dropped nearly 2.5% in pre-market trading, with Q1 results exceeding expectations, revenue at $77.7 billion, and EPS at $3.72, but capital expenditures surged to $34.9 billion, raising market concerns about "burning money" on AI infrastructure.

⑩ It is reported that OpenAI is preparing to submit an IPO application as early as next year, with a valuation potentially reaching $1 trillion, and plans to raise at least $60 billion